NCT00328575
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +9 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
Clinical trial condition
Neoplasm Metastasis
Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.
212 public trials
12 recruiting studies
Neoplasm Metastasis trial results
NCT00280475
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +9 more
- Locations
-
- Nagoya University School of Medicine Nagoya,Showa-ku,Tsurumai-cho,65, Aichi-ken, Japan
- Chiba University, Graduate School of Medicine Chiba,Chuo-ku,Inohana,1-8-1, Chiba, Japan
- Ehime University Hospital Shitsukawa,Toon, Ehime, Japan
- Kyushu University Hospital Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan
NCT00190489
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- National Cancer Center Hospital Chuo-ku, Tsukiji, 5-1-1, Tokyo, Japan
Completed
FoundationOne™ Test Registry Study
NCT01851213
- Conditions
- Cancer, Neoplasm Metastasis, Neoplasms, +4 more
- Locations
-
- Evergreen Hematology/Oncology Spokane, Washington, United States
Completed
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
NCT00519285
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office Buenos Aires, Argentina
- Sanofi-Aventis Administrative Office Macquarie Park, Australia
- Sanofi-Aventis Administrative Office Diegem, Belgium
NCT00851084
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +14 more
- Locations
-
- Sanofi-Aventis Investigational Site Number 036004 Douglas, Australia
- Sanofi-Aventis Investigational Site Number 036001 Hunter Region Mail Centre, Australia
- Sanofi-Aventis Investigational Site Number 036003 Hunter Region Mail Centre, Australia
- Sanofi-Aventis Investigational Site Number 276003 Berlin, Germany
NCT00271687
- Conditions
- Behavior, Genital Diseases, Genital Diseases, Male, +14 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
NCT00207116
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Local Institution Newark, Delaware, United States
NCT00377559
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
- Wilhelmina Ziekenhuis Assen, Netherlands
- Catharina-Ziekenhuis Eindhoven, Netherlands
- Ziekenhuis Walcheren Flushing, Netherlands
NCT01441596
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +7 more
- Locations
-
- 1200.67.10106 Boehringer Ingelheim Investigational Site Bakersfield, California, United States
- 1200.67.10105 Boehringer Ingelheim Investigational Site Fullerton, California, United States
- 1200.67.10001 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
- 1200.67.10108 Boehringer Ingelheim Investigational Site Santa Barbara, California, United States